Catalytic 1,2-Dicyanation of Alkynes by Palladium(II) under Aerobic Conditions
FULL PAPERS
(ATR): n=3071, 2931, 2230, 1428, 1108 cmÀ1; LR-MS (EI):
m/z=374 (M+), 359 (M+ÀMe), 317 (M+Àt-Bu), 208, 197,
183, 77; HR-MS (FAB): m/z=375.1880, calcd. for
C23H27N2OSi (M+ +H): 375.1893.
2-[3-(tert-Butyldiphenylsilyloxy)propyl]fumaronitrile
(anti-2h): mp 59–628C; 1H NMR (400 MHz, CDCl3): d=
1.07 (s, 9H), 1.84–1.92 (m, 2H), 2.76 (t, J=7.6 Hz, 2H), 3.72
(t, J=5.6 Hz, 2H), 5.94 (s, 1H), 7.36–7.47 (m, 6H), 7.65–
7.67 (m, 4H); 13C NMR (100 MHz, CDCl3): d=19.1, 26.7,
30.2, 30.6, 62.2, 112.1, 113.3, 116.0, 127.1, 129.8, 133.2, 135.5,
136.8; IR (ATR): n=3071, 2931, 2231, 1428, 1106 cmÀ1; LR-
MS (EI): m/z=374 (M+), 317 (M+Àt-Bu), 208, 199, 183, 77;
HR-MS (EI): m/z=374.1826, calcd. for C23H26N2OSi (M+):
374.1814.
2.32 (dq, J=14.8, 7.2 Hz, 1H), 2.44 (dq, J=14.8, 7.2 Hz,
1H), 3.13 (s, 3H), 6.07 (s, 1H), 7.35–7.45 (m, 5H); 13C NMR
(100 MHz, CDCl3): d=6.8, 24.9, 50.3, 83.3, 111.2, 113.5,
115.6, 126.9, 129.1, 129.2, 138.1, 140.4; IR (ATR): n=2942,
2234, 1447, 1065 cmÀ1; LR-MS (EI): m/z=226 (M+), 197
(M+ÀEt), 165 (M+ÀOMeÀMe), 149 (M+ÀPh), 105; HR-MS
(EI): m/z=226.1117, calcd. for C14H14N2O (M+): 226.1106 .
2-Butyl-3-phenylmaleonitrile
(syn-4f):
1H NMR
(400 MHz, CDCl3): d=0.89 (t, J=7.6 Hz, 3H), 1.30–1.39
(m, 2H), 1.61–1.70 (m, 2H), 2.49 (t, J=7.6 Hz, 2H), 7.27–
7.39 (m, 2H), 7.47–7.51 (m, 3H); 13C NMR (100 MHz,
CDCl3): d=13.5, 22.0, 29.9, 30.9, 116.2, 116.4, 127.3, 128.6,
129.2, 129.8, 130.4, 130.8; IR (ATR): n=2960, 2221, 1445,
1021 cmÀ1; LR-MS (EI): m/z=210 (M+), 168, 154, 141; HR-
MS (EI): m/z=210.1150, calcd. for C14H14N2 (M+): 210.1157.
2-[3-(tert-Butyldimethylsilyloxy)propyl]maleonitrile (syn-
2i): 1H NMR (400 MHz, CDCl3): d=0.07 (s, 6H), 0.90 (s,
9H), 1.89 (tt, J=7.2, 6.0 Hz, 2H), 2.72 (dt, J=7.2, 1.2 Hz,
2H), 3.70 (t, J=6.0 Hz, 2H), 5.95 (t, J=1.2 Hz, 1H);
13C NMR (100 MHz, CDCl3): d=À5.5, 18.2, 25.9, 30.4, 30.7.
61.4, 112.0, 113.3, 116.1, 137.2; IR (ATR): n=3061, 2232,
1609, 1104 cmÀ1; LR-MS (FAB): m/z=251 (M+ +H), 235
(M+ÀMe), 193 (M+Àt-Bu), 73; HR-MS (FAB): m/z=
251.1566, calcd. for C12H21N2OSi (M+ +H): 251.1580.
2-[2-(tert-Butyldimethylsilyloxy)propyl]fumaronitrile
2-Butyl-3-phenylfumaronitrile
(anti-4f):
1H NMR
(400 MHz, CDCl3): d=1.01 (t, J=7.6 Hz, 3H), 1.52–1.61
(m, 2H), 1.71–1.80 (m, 2H), 2.79 (t, J=7.6 Hz, 2H), 7.27–
7.39 (m, 2H), 7.47–7.51 (m, 3H); 13C NMR (100 MHz,
CDCl3): d=13.6, 21.9, 30.0, 35.3, 115.5, 116.4, 127.2, 128.2,
128.6, 129.1, 130.9, 131.3; IR (ATR): n=2960, 2872, 2224,
1446 cmÀ1; LR-MS (EI): m/z=210 (M+), 168, 154, 141; HR-
MS (EI): m/z=210.1154, calcd. for C14H14N2 (M+): 210.1157.
(Z)-N-(2,3-Dicyanobut-2-enyl)-4-methyl-N-phenylben-
1
(anti-2i): H NMR (400 MHz, CDCl3): d=0.05 (s, 6H), 0.90
AHCTUNGTRENNUNG
zenesulfonamide (syn-6a): mp 598C; 1H NMR (400 MHz,
(s, 9H), 1.83 (tt, J=6.8, 5.6 Hz, 2H), 2.55 (dt, J=6.8, 1.6 Hz,
2H), 3.65 (t, J=5.6 Hz, 2H), 5.90 (t, J=1.6 Hz, 1H);
13C NMR (100 MHz, CDCl3): d=À5.4, 18.2, 25.9, 30.0, 32.1.
60.9, 111.7, 113.8, 128.6, 136.4; IR (ATR): n=3062, 2858,
2231, 1609, 1110 cmÀ1; LR-MS (FAB): m/z=251 (M+ +H),
235 (M+ÀMe), 193 (M+Àt-Bu), 73; HR-MS (FAB): m/z=
251.1598, calcd. for C12H21N2OSi (M+ +H): 251.1580.
CDCl3): d=2.11 (s, 3H), 2.45 (s, 3H), 4.45 (s, 2H), 7.07–7.10
(m, 2H), 7.25–7.30 (m, 3H), 7.34–7.38 (m, 3H), 7.50 (d, J=
8.0 Hz, 2H); 13C NMR (150 MHz, CDCl3): d=17.5, 21.7,
49.3, 115.3, 116.4, 125.1, 127.4, 127.9, 128.9, 129.2, 129.7,
129.9, 134.2, 138.4, 144.8; IR (ATR): n=2225, 1596, 1491,
1346, 1161, 1088 cmÀ1; LR-MS (EI): m/z=351 (M+), 247,
196, 155, 91; HR-MS (EI): m/z=351.1051, calcd. for
C19H17N3O2S (M+): 351.1041.
2-[3-(4-Morpholino)-3-oxopropyl]maleonitrile
(syn-2j):
1H NMR (400 MHz, CDCl3): d=2.65 (t, J=6.8 Hz, 2H),
2.81 (t, J=6.8 Hz, 2H), 3.46 (t, J=4.8 Hz, 2H), 3.61 (t, J=
4.8 Hz, 2H), 3.66–3.73 (m, 4H), 6.01 (s, 1H); 13C NMR
(100 MHz, CDCl3): d=28.5, 29.9, 42.1, 45.6, 66.3, 66.7,
113.0, 113.3, 115.8, 135.6, 167.9; IR (ATR): n=2918, 2228,
1645, 1444, 1115 cmÀ1; LR-MS (EI): m/z=219 (M+), 133,
127, 86; HRMS (FAB): m/z=220.1076, calcd. for C12H14N3
O2 (M+ +H): 220.1086.
(E)-N-(2,3-Dicyanobut-2-enyl)-4-methyl-N-phenylben-
AHCTUNGTRENNUNG
zenesulfonamide (anti-6a): mp 638C; 1H NMR (400 MHz,
CDCl3): d=2.20 (s, 3H), 2.45 (s, 3H), 4.57 (s, 2H), 7.08–7.12
(m, 2H), 7.20–7.42 (m, 6H), 7.50–7.60 (m, 2H); 13C NMR
(100 MHz, CDCl3): d=20.0, 21.5, 52.1, 113.8, 115.0, 125.9,
126.0, 127.8, 128.6, 128.8, 129.3, 129.6, 133.8, 138.3, 144.4; IR
(ATR): n=2232, 1596, 1488, 1326, 1154, 1088 cmÀ1; LR-MS
(EI): m/z: 351 (M+), 247, 196, 155, 91, 58; HR-MS (EI):
m/z=351.1043, calcd. for C19H17N3O2S (M+): 351.1041.
(Z)-N-(3,4-Dicyanopent-3-enyl)-4-methyl-N-phenylben-
2-[3-(4-Morpholino)-3-oxopropyl]fumaronitrile (anti-2j):
mp 70–758C; 1H NMR (400 MHz, CDCl3): d=2.70 (t, J=
6.8 Hz, 2H), 2.95 (t, J=6.8 Hz, 2H), 3.47 (t, J=4.8 Hz, 2H),
3.63 (t, J=4.8 Hz, 2H), 3.66–3.73 (m, 4H), 6.10 (s, 1H);
13C NMR (100 MHz, CDCl3): d=29.8, 30.0, 42.1, 45.6, 66.3,
66.7, 113.5, 114.7, 115.3, 134.7, 168.0; IR (ATR): n=2918,
2228, 1645, 1444, 1115 cmÀ1; LR-MS (EI): m/z=219 (M+),
127, 86; HR-MS (FAB): m/z=220.1094, calcd. for
C12H14N3O2 (M+ +H): 220.1086.
2-(1-Methoxy-1-phenylpropyl)maleonitrile (syn-2p): mp
97–1008C: 1H NMR (600 MHz, CDCl3): d=0.92 (t, J=
7.2 Hz, 3H), 2.29 (dq, J=14.6, 7.2 Hz, 1H), 2.38 (dq, J=
14.6, 7.2 Hz, 1H), 3.05 (s, 3H), 6.53 (s, 1H), 7.34–7.39 (m,
3H), 7.41–7.44 (m, 2H); 13C NMR (100 MHz, CDCl3): d=
6.7, 24.1, 50.6, 82.0, 111.0, 113.5, 114.1, 126.9, 129.0, 129.05,
129.14, 137.3, 140.7; IR (ATR): n=3074, 2987, 2231, 1447,
1067 cmÀ1; LR-MS (EI): m/z=226 (M+), 196 (M+À2Me),
165 (M+ÀOMeÀMe), 149 (M+ÀPh), 105, 77; HR-MS (EI):
m/z=226.1105, calcd. for C14H14N2O (M+): 226.1106.
AHCTUNGTRENNUNG
zenesulfonamide (syn-6b): mp 1488C; 1H NMR (400 MHz,
CDCl3): d=2.07 (s, 3H), 2.43 (s, 3H), 2.68 (t, J=6.8 Hz,
2H), 3.78 (d, J=6.8 Hz, 2H), 7.01–7.05 (m, 2H), 7.25 (d, J=
8.4 Hz, 2H), 7.32–7.36 (m, 3H), 7.42 (d, J=8.4 Hz, 2H);
13C NMR (100 MHz, CDCl3): d=17.5, 21.7, 31.1, 48.5, 115.7,
116.6, 125.8, 126.1, 127.8, 128.5, 128.7, 129.5, 129.7, 134.2,
139.1, 144.2; IR (ATR): n=2927, 2222, 1594, 1341,
1159 cmÀ1; LR-MS (EI): m/z=365 (M+), 260, 155, 91; HR-
MS (EI): m/z=365.1199, calcd. for C20H19N3O2S (M+):
365.1198.
(Z)-N-Benzyl-N-(2,3-dicyanobut-2-enyl)-4-methylben-
AHCTUNGTRENNUNG
zenesulfonamide (syn-6d): mp 157–1598C; 1H NMR
(400 MHz, CDCl3): d=1.96 (s, 3H), 2.48 (s, 3H), 3.97 (s,
2H), 4.45 (s, 2H), 7.25–7.46 (m, 7H), 7.77 (d, J=8.0 Hz,
2H); 13C NMR (100 MHz, CDCl3): d=17.2, 21.6, 44.7, 52.8,
115.2, 115.9, 124.9, 126.4, 127.4, 128.7, 128.8, 129.0, 130.1,
134.2, 135.4, 144.6; IR (ATR): n=2926, 2225, 1329, 1158,
1102 cmÀ1; LR-MS (EI): m/z=365 (M+), 260, 252, 210, 155,
2-(1-Methoxy-1-phenylpropyl)fumaronitrile
(anti-2p):
1H NMR (400 MHz, CDCl3): d=1.00 (t, J=7.2 Hz, 3H),
Adv. Synth. Catal. 2009, 351, 1897 – 1904
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1903